Skip to main content
Sandoz Group AG on Muck Rack

Sandoz Group AG

As seen in: FinanzNachrichten.de, Sparda-Bank web.Börsenforum
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sandoz Group

Contact Sandoz Group, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PSD Bank Rhein-Ruhr eG

|
By Sandoz Group AG, Richard Saynor, Inc.'s cutting-edge
| Sparda-Bank web.Börsenforum
Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth Sandoz Group AG / Key word(s): Annual Results Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth 25-Feb-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.
Open in Who Shared View Duplicates (14) Issue with article?

PSD Bank Rhein-Ruhr eG

|
By Sandoz Group AG, Sandoz holds, excluding Germany
| Sparda-Bank web.Börsenforum
Sandoz confirms European Commission approval for Ranluspec® (ranibizumab), further strengthening overall biosimilars leadership and position in ophthalmology Sandoz Group AG / Key word(s): Regulatory Approval Sandoz confirms European Commission approval for Ranluspec® (ranibizumab), further strengthening overall biosimilars leadership and position in ophthalmology 23.02.2026 / 11:00 CET/CEST _____________________________________________________________ MEDIA RELEASE * Biosimilar Ranluspec...
Open in Who Shared View Duplicates (23) Issue with article?

Sandoz receives US FDA approval to expand Enzeevu (aflibercept-abzv) label for multiple retinal indications

|
By Sandoz Group AG, Diabetic Retinopathy
| FinanzNachrichten.de
DJ Sandoz receives US FDA approval to expand Enzeevu (aflibercept-abzv) label for multiple retinal indications Sandoz Group AG / Key word(s): Regulatory Approval Sandoz receives US FDA approval to expand Enzeevu (aflibercept-abzv) label for multiple retinal indications 2026-02-18 / 07:00 CET/CEST =---------------------------------------------------------------------------------------------------------------------- MEDIA RELEASE -- Approved indications now include all retinal indications, in...
Open in Who Shared View Duplicates (22) Issue with article?
See all 13 articles